Concepedia

Deborah Bayley

DB

Statistics

Publications

6

Citations

347

H-Index

6

Active since

1994

Affiliations

Novartis (United Kingdom)(Current)

Ionis Pharmaceuticals (United States)

East Sussex County Council

Deborah Bayley is an author at Novartis (United Kingdom) specializing in pharmacokinetics, pharmacy, and bioavailability.

Publications per year

1994–2003

6

Publications

6

Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration

J. A. Phillips, S. J. Craig, Deborah Bayley et al. · Biochemical Pharmacology · 1997 · 122 citations

, , +12

Proteolytic activity of the house dust mite allergen Der p 1 enhances allergenicity in a mouse inhalation model

Lucy Gough, Emma M. Campbell, Deborah Bayley et al. · Clinical & Experimental Allergy · 2003 · 77 citations

, , +17

Pulmonary Bioavailability of a Phosphorothioate Oligonucleotide (CGP 64128A): Comparison with Other Delivery Routes

Paul Nicklin, Deborah Bayley, June Giddings et al. · Pharmaceutical Research · 1998 · 61 citations

, , +16

The effect of enhancers on the buccal absorption of hybrid (BDBB) α-interferon

A. Steward, Deborah Bayley, Christine A. Howes · International Journal of Pharmaceutics · 1994 · 59 citations

, , +9

The Transmucosal Absorption of Recombinant Human Interferon-α B/D Hybrid in the Rat and Rabbit

Deborah Bayley, Cathy Temple, Val E. Clay et al. · Journal of Pharmacy and Pharmacology · 1995 · 16 citations

, , +14

1–5 of 6